Listing items by Author "Menéndez Menéndez, Javier Abel"

49 items found

Showing titles from 0 to 25:

  1  2   
FormatDateTitleAuthor
FormatDateTitleAuthor
doc icon DUGiDocs 2012 Androgen-independent prostate cancer cells circumvent EGFR inhibition by overexpression of alternative HER receptors and ligands Carrion Salip, Dolors ; Panosa Roqueta, Clara ; Menéndez Menéndez, Javier Abel ; Puig, Teresa ; Oliveras, Glòria ; Pandiella, Atanasio ; Llorens Duran, Rafael de ; Massaguer i Vall-llovera, Anna
out url icon Recercat Androgen-independent prostate cancer cells circumvent EGFR inhibition by overexpression of alternative HER receptors and ligands Carrion Salip, Dolors ; Panosa Roqueta, Clara ; Menéndez Menéndez, Javier Abel ; Puig, Teresa ; Oliveras, Glòria ; Pandiella, Atanasio ; Llorens Duran, Rafael de ; Massaguer i Vall-llovera, Anna
out url icon Recercat Androgen-independent prostate cancer cells circumvent EGFR inhibition by overexpression of alternative HER receptors and ligands Carrion Salip, Dolors ; Panosa Roqueta, Clara ; Menéndez Menéndez, Javier Abel ; Puig, Teresa ; Oliveras, Glòria ; Pandiella, Atanasio ; Llorens Duran, Rafael de ; Massaguer i Vall-llovera, Anna
out url icon Recercat 2018 June 5 Androgen-independent prostate cancer cells circumvent EGFR inhibition by overexpression of alternative HER receptors and ligands Carrion Salip, Dolors ; Panosa Roqueta, Clara ; Menéndez Menéndez, Javier Abel ; Puig, Teresa ; Oliveras, Glòria ; Pandiella, Atanasio ; Llorens Duran, Rafael de ; Massaguer i Vall-llovera, Anna
out url icon Recercat Bioenergetics mechanism and autophagy in breast cancer stem cells Cufí González, Sílvia
doc icon DUGiDocs 2017 BRCA1 haploinsufficiency cell-autonomously activates RANKL expression and generates denosumab-responsive breast cancerinitiating cells Cuyàs, Elisabet ; Corominas Faja, Bruna ; Muñoz-San Martín, María ; Martin Castillo, Begoña ; Lupu, Ruth ; Brunet i Vidal, Joan ; Bosch Barrera, Joaquim ; Menéndez Menéndez, Javier Abel
out url icon Recercat BRCA1 haploinsufficiency cell-autonomously activates RANKL expression and generates denosumab-responsive breast cancerinitiating cells Cuyàs, Elisabet ; Corominas Faja, Bruna ; Muñoz-San Martín, María ; Martin Castillo, Begoña ; Lupu, Ruth ; Brunet i Vidal, Joan ; Bosch Barrera, Joaquim ; Menéndez Menéndez, Javier Abel
out url icon Recercat BRCA1 haploinsufficiency cell-autonomously activates RANKL expression and generates denosumab-responsive breast cancerinitiating cells Cuyàs, Elisabet ; Corominas Faja, Bruna ; Muñoz-San Martín, María ; Martin Castillo, Begoña ; Lupu, Ruth ; Brunet i Vidal, Joan ; Bosch Barrera, Joaquim ; Menéndez Menéndez, Javier Abel
out url icon Recercat 2018 June 5 BRCA1 haploinsufficiency cell-autonomously activates RANKL expression and generates denosumab-responsive breast cancerinitiating cells Cuyàs, Elisabet ; Corominas Faja, Bruna ; Muñoz-San Martín, María ; Martin Castillo, Begoña ; Lupu, Ruth ; Brunet i Vidal, Joan ; Bosch Barrera, Joaquim ; Menéndez Menéndez, Javier Abel
doc icon DUGiDocs 2011 Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models Oliveras Ferrarós, Cristina ; Vázquez Martín, Alejandro ; Queralt, Bernardo ; Adrados, Manuel ; Ortiz, Rosa ; Cufí González, Sílvia ; Hernández Yagüe, Xavier ; Guardeño, Raquel ; Báez, Luciana ; Martin Castillo, Begoña ; Pérez Martínez, Maria Carmen ; López Bonet, Eugeni ; Llorens Duran, Rafael de ; Bernadó, Luis ; Brunet i Vidal, Joan ; Menéndez Menéndez, Javier Abel
out url icon Recercat Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models Oliveras Ferrarós, Cristina ; Vázquez Martín, Alejandro ; Queralt, Bernardo ; Adrados, Manuel ; Ortiz, Rosa ; Cufí González, Sílvia ; Hernández Yagüe, Xavier ; Guardeño, Raquel ; Báez, Luciana ; Martin Castillo, Begoña ; Pérez Martínez, Maria Carmen ; López Bonet, Eugeni ; Llorens Duran, Rafael de ; Bernadó, Luis ; Brunet i Vidal, Joan ; Menéndez Menéndez, Javier Abel
out url icon Recercat Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models Oliveras Ferrarós, Cristina ; Vázquez Martín, Alejandro ; Queralt, Bernardo ; Adrados, Manuel ; Ortiz, Rosa ; Cufí González, Sílvia ; Hernández Yagüe, Xavier ; Guardeño, Raquel ; Báez, Luciana ; Martin Castillo, Begoña ; Pérez Martínez, Maria Carmen ; López Bonet, Eugeni ; Llorens Duran, Rafael de ; Bernadó, Luis ; Brunet i Vidal, Joan ; Menéndez Menéndez, Javier Abel
out url icon Recercat 2018 June 5 Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models Oliveras Ferrarós, Cristina ; Vázquez Martín, Alejandro ; Queralt, Bernardo ; Adrados, Manuel ; Ortiz, Rosa ; Cufí González, Sílvia ; Hernández Yagüe, Xavier ; Guardeño, Raquel ; Báez, Luciana ; Martin Castillo, Begoña ; Pérez Martínez, Maria Carmen ; López Bonet, Eugeni ; Llorens Duran, Rafael de ; Bernadó, Luis ; Brunet i Vidal, Joan ; Menéndez Menéndez, Javier Abel
doc icon DUGiDocs 2012 April Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts Cufí González, Sílvia ; Corominas Faja, Bruna ; Vázquez Martín, Alejandro ; Oliveras Ferrarós, Cristina ; Dorca Ribugent, Joan ; Bosch Barrera, Joaquim ; Martin Castillo, Begoña ; Menéndez Menéndez, Javier Abel
out url icon Recercat Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts Cufí González, Sílvia ; Corominas Faja, Bruna ; Vázquez Martín, Alejandro ; Oliveras Ferrarós, Cristina ; Dorca Ribugent, Joan ; Bosch Barrera, Joaquim ; Martin Castillo, Begoña ; Menéndez Menéndez, Javier Abel
out url icon Recercat Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts Cufí González, Sílvia ; Corominas Faja, Bruna ; Vázquez Martín, Alejandro ; Oliveras Ferrarós, Cristina ; Dorca Ribugent, Joan ; Bosch Barrera, Joaquim ; Martin Castillo, Begoña ; Menéndez Menéndez, Javier Abel
out url icon Recercat 2018 June 5 Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts Cufí González, Sílvia ; Corominas Faja, Bruna ; Vázquez Martín, Alejandro ; Oliveras Ferrarós, Cristina ; Dorca Ribugent, Joan ; Bosch Barrera, Joaquim ; Martin Castillo, Begoña ; Menéndez Menéndez, Javier Abel
doc icon TDX 2013 June 21 Nous mecanismes de resistència primària al trastuzumab (Herceptin): bases moleculars per a la determinació d’un nou subtipus de càncer de mama (Basal/ErbB2+) Oliveras Ferrarós, Cristina
out url icon Recercat Nous mecanismes de resistència primària al trastuzumab (Herceptin): bases moleculars per a la determinació d’un nou subtipus de càncer de mama (Basal/ErbB2+) Oliveras Ferrarós, Cristina
doc icon DUGiDocs 2014 Oncobiguanides: Paracelsus’ law and nonconventional routes for administering diabetobiguanides for cancer treatment Menéndez Menéndez, Javier Abel ; Quirantes Piné, Rosa ; Rodríguez Gallego, Esther ; Cufí González, Sílvia ; Corominas Faja, Bruna ; Cuyàs, Elisabet ; Bosch Barrera, Joaquim ; Martin Castillo, Begoña ; Segura Carretero, Antonio ; Joven, Jorge
out url icon Recercat Oncobiguanides: Paracelsus’ law and nonconventional routes for administering diabetobiguanides for cancer treatment Menéndez Menéndez, Javier Abel ; Quirantes Piné, Rosa ; Rodríguez Gallego, Esther ; Cufí González, Sílvia ; Corominas Faja, Bruna ; Cuyàs, Elisabet ; Bosch Barrera, Joaquim ; Martin Castillo, Begoña ; Segura Carretero, Antonio ; Joven, Jorge
out url icon Recercat Oncobiguanides: Paracelsus’ law and nonconventional routes for administering diabetobiguanides for cancer treatment Menéndez Menéndez, Javier Abel ; Quirantes Piné, Rosa ; Rodríguez Gallego, Esther ; Cufí González, Sílvia ; Corominas Faja, Bruna ; Cuyàs, Elisabet ; Bosch Barrera, Joaquim ; Martin Castillo, Begoña ; Segura Carretero, Antonio ; Joven, Jorge
out url icon Recercat 2018 June 5 Oncobiguanides: Paracelsus’ law and nonconventional routes for administering diabetobiguanides for cancer treatment Menéndez Menéndez, Javier Abel ; Quirantes Piné, Rosa ; Rodríguez Gallego, Esther ; Cufí González, Sílvia ; Corominas Faja, Bruna ; Cuyàs, Elisabet ; Bosch Barrera, Joaquim ; Martin Castillo, Begoña ; Segura Carretero, Antonio ; Joven, Jorge
doc icon DUGiDocs 2015 Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype Cuyàs, Elisabet ; Fernández Arroyo, Salvador ; Corominas Faja, Bruna ; Rodríguez Gallego, Esther ; Bosch Barrera, Joaquim ; Martin Castillo, Begoña ; Llorens Duran, Rafael de ; Joven, Jorge ; Menéndez Menéndez, Javier Abel
out url icon Recercat Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype Cuyàs, Elisabet ; Fernández Arroyo, Salvador ; Corominas Faja, Bruna ; Rodríguez Gallego, Esther ; Bosch Barrera, Joaquim ; Martin Castillo, Begoña ; Llorens Duran, Rafael de ; Joven, Jorge ; Menéndez Menéndez, Javier Abel
  1  2   

Subjects

Authors